Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Wiehle Ronald
 2. Date of Event Requiring Statement (Month/Day/Year)
01/04/2007		 3. Issuer Name and Ticker or Trading Symbol
REPROS THERAPEUTICS INC. [RPRX]
(Last)
(First)
(Middle)
2408 TIMBERLOCH PLACE, SUITE B-7		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Vice President, R&D
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

THE WOODLANDS, TX 77380		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 22,016
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (1) 10/31/2007 Common Stock 5,000 $ 33.25 D  
Stock Option (right to buy)   (1) 10/15/2007 Common Stock 1,250 $ 18.19 D  
Stock Option (right to buy) 09/29/2001 09/29/2010 Common Stock 4,000 $ 3.47 D  
Stock Option (right to buy)   (2) 02/01/2011 Common Stock 1,000 $ 18.19 D  
Stock Option (right to buy)   (2) 02/01/2011 Common Stock 4,000 $ 33.25 D  
Stock Option (right to buy)   (1) 09/20/2011 Common Stock 25,000 $ 3.15 D  
Stock Option (right to buy)   (3) 03/29/2014 Common Stock 27,362 $ 2.72 D  
Stock Option (right to buy)   (4) 03/29/2014 Common Stock 17,139 $ 2.72 D  
Stock Option (right to buy)   (3) 03/29/2014 Common Stock 75,988 $ 2.72 D  
Stock Option (right to buy)   (5) 03/29/2014 Common Stock 10,003 $ 2.72 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Wiehle Ronald
2408 TIMBERLOCH PLACE
SUITE B-7
THE WOODLANDS, TX 77380		       Vice President, R&D  

Signatures

/s/ Ronald Wiehle, PhD 01/11/2007
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The option vests and becomes exercisable annually at a rate of 20% of the shares subject to the option.
(2) The option vested and became exercisable at a rate of 50% of the shares on the date of grant, 25% of the shares on 12/31/2001 and the remaining 25% of the shares on 12/31/2002.
(3) The option vests and becomes exercisable at a rate of 1/12th per quarter for a period of 3 years.
(4) The option vests and becomes exercisable in equal installments over a period of 9 months.
(5) The option vests and becomes exercisable based on certain milestones assigned by the Board of Directors.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.